Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06298669 · ClinicalTrials.gov registry record · NA
Biventricular Versus Right Ventricular Pacing
A NA study, sponsored by Indiana University.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT06298669: Clinical Trial NA study, sponsored by Indiana University.
NCT06298669 is a NA study that was terminated before completion, run by Indiana University. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06298669, a NA study, was terminated before completion, sponsored by Indiana University.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
The study is a randomized, single-blind crossover prospective study in which investigators will determine the clinical outcomes of cardiac resynchronization therapy (CRT) pacing modalities in patients with left ventricular assist devices (LVAD). Only patients are blinded. This is a small-scale study from which future larger scale randomized controls can be performed. The primary endpoint will be the effect of BiV and RV pacing setting on the 6-minute walk test.
Primary Outcome
The distance walked over 6 minutes was measured at the baseline visit and the visit three months after baseline. The six month visit did not occur because the study was terminated.
Interventions
- DEVICE Biventricular Pacing
- DEVICE Right Ventricular Pacing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2023-08-09 |
| Est. Completion | 2023-11-10 |
| Phase | NA |
Why NCT06298669 stopped before completion
NCT06298669 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Biventricular Pacing is the first listed.
NCT06298669 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06298669 about?
NCT06298669 is a clinical study titled "Biventricular Versus Right Ventricular Pacing". The study is a randomized, single-blind crossover prospective study in which investigators will determine the clinical outcomes of cardiac resynchronization therapy (CRT) pacing modalities in patients with left ventricular assist devices (LVAD). Only patients are blinded. This is a small-scale study...
What is the current status of trial NCT06298669?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2023-08-09. Estimated completion is 2023-11-10.
What interventions are being tested in trial NCT06298669?
The interventions under investigation include: Biventricular Pacing (DEVICE), Right Ventricular Pacing (DEVICE).
Who is sponsoring clinical trial NCT06298669?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06298669's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI